Structural basis for GTP-induced dimerization and antiviral function of guanylate-binding proteins

Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2022269118. doi: 10.1073/pnas.2022269118.

Abstract

Guanylate-binding proteins (GBPs) form a family of dynamin-related large GTPases which mediate important innate immune functions. They were proposed to form oligomers upon GTP binding/hydrolysis, but the molecular mechanisms remain elusive. Here, we present crystal structures of C-terminally truncated human GBP5 (hGBP51-486), comprising the large GTPase (LG) and middle (MD) domains, in both its nucleotide-free monomeric and nucleotide-bound dimeric states, together with nucleotide-free full-length human GBP2. Upon GTP-loading, hGBP51-486 forms a closed face-to-face dimer. The MD of hGBP5 undergoes a drastic movement relative to its LG domain and forms extensive interactions with the LG domain and MD of the pairing molecule. Disrupting the MD interface (for hGBP5) or mutating the hinge region (for hGBP2/5) impairs their ability to inhibit HIV-1. Our results point to a GTP-induced dimerization mode that is likely conserved among all GBP members and provide insights into the molecular determinants of their antiviral function.

Keywords: GTP-induced dimerization; antiviral factors; furin inhibition; guanylate-binding proteins; innate immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • GTP-Binding Proteins / chemistry*
  • GTP-Binding Proteins / genetics
  • GTP-Binding Proteins / metabolism
  • Guanosine Triphosphate / chemistry
  • Guanosine Triphosphate / metabolism
  • HEK293 Cells
  • Humans
  • Molecular Dynamics Simulation
  • Protein Binding
  • Protein Multimerization*
  • env Gene Products, Human Immunodeficiency Virus / chemistry
  • env Gene Products, Human Immunodeficiency Virus / metabolism

Substances

  • GBP5 protein, human
  • env Gene Products, Human Immunodeficiency Virus
  • Guanosine Triphosphate
  • GBP2 protein, human
  • GTP-Binding Proteins